STACEY RILEY: Open Payments
NPI 1831767664 · WOODBRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 44 payments from 23 companies in 2025. Trend: 2023 $776 · 2024 $944 · 2025 $1,165
Food & beverage: $1,002Education: $163
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $243 |
| ABBVIE INC. | 8 | $128 |
| Incyte Corporation | 3 | $121 |
| Daiichi Sankyo Inc. | 3 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Aveo Pharmaceuticals, Inc. | 2 | $51 |
| Pharmacosmos Therapeutics Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: Wegovy, Ozempic, Enhertu, FOTIVDA, Nubeqa, MONOFERRIC, OJJAARA, IMBRUVICA.
Industry payments across NJ — which companies pay providers there.
